New Phase Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Series A
- (In Progress)
- Latest Deal Amount
-
$25M
- Investors
-
4
New Phase General Information
Description
Developer of a medical technology platform designed to provide minimally invasive cancer treatment. The company offers nanoparticle-based therapy integrated with an electromagnetic induction system for targeted treatment, enabling healthcare providers treating cancer patients, to destroy cancerous cells while preserving healthy tissue and improving patient outcomes.
Contact Information
Website
newphase.co.ilCorporate Office
- 5 Odem Street
- P.O Box 6761
- Petah Tikva 4934829
- Israel
Corporate Office
- 5 Odem Street
- P.O Box 6761
- Petah Tikva 4934829
- Israel
New Phase Timeline
New Phase Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series A) | $25M | In Progress | Generating Revenue | |||
| 10. Later Stage VC | 30-Jun-2025 | Completed | Clinical Trials - Phase 1 | |||
| 9. Later Stage VC (Series 3) | 02-Jun-2024 | Completed | Clinical Trials - Phase 1 | |||
| 8. Later Stage VC (Series 1) | 01-Jan-2024 | Completed | Clinical Trials - Phase 1 | |||
| 7. Later Stage VC | 02-Jan-2022 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC | 01-Mar-2018 | Completed | Pre-Clinical Trials | |||
| 5. Angel (individual) | 01-Jan-2017 | Completed | Pre-Clinical Trials | |||
| 4. Angel (individual) | 01-Jan-2016 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 01-Jan-2014 | $2M | $2.8M | Completed | Product In Beta Test | |
| 2. Angel (individual) | 01-Aug-2013 | $400K | $800K | Completed | Product In Beta Test |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
New Phase Patents
New Phase Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12667732-B2 | Pulsed electromagnetic field transmission for nanoparticles | Active | 09-Oct-2024 | ||
| US-20260097223-A1 | Pulsed electromagnetic field transmission for nanoparticles | Active | 09-Oct-2024 | ||
| US-20260306865-A1 | Pulsed electromagnetic field transmission for nanoparticles | Pending | 09-Oct-2024 | ||
| WO-2025088597-A1 | Nanoparticle combination therapy for tumors | Inactive | 26-Oct-2023 | ||
| CA-3054033-A1 | Phase-change nanoparticle | Active | 22-Feb-2017 | A61N1/406 |
New Phase Signals
New Phase Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Katao Venture Partners | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Real Life Innovations | Venture Capital | Minority | ||
| Innovation Authority | Government | Minority |
New Phase FAQs
-
When was New Phase founded?
New Phase was founded in 2013.
-
Where is New Phase headquartered?
New Phase is headquartered in Petah Tikva, Israel.
-
What is the size of New Phase?
New Phase has 25 total employees.
-
What industry is New Phase in?
New Phase’s primary industry is Therapeutic Devices.
-
Is New Phase a private or public company?
New Phase is a Private company.
-
What is New Phase’s current revenue?
The current revenue for New Phase is .
-
How much funding has New Phase raised over time?
New Phase has raised $68.6M.
-
Who are New Phase’s investors?
Katao Venture Partners, , Real Life Innovations, and Innovation Authority have invested in New Phase.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process